Objectives

After participating in this educational activity, attendees should be able to:
1. Define neontal/infantile sepsis
2. List common pathogens associated with neonatal/infantile sepsis
3. Identify risk factors for neonatal/infantile sepsis

4. Evaluate antimicrobial drug therapy regimens for patients being treated for rule out neonatal/infantile sepsis

5. Review how to verify orders for neonatal/infantile sepsis in Cerner

Faculty

Evan Horton, PharmD, BCPPS
Associate Professor of Pharmacy Practice
MCPHS University

Frank Szczerba, PharmD, BCPPS, BCPS, AAHIVP
Clinical Pharmacist III/Pedi Care Team Lead
Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.